Archives

by in
Entry Author Date Location
Calithera BioSciences Nabs $35M for Cancer Drugs 10/29/13 San Francisco
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 08/25/13 San Francisco
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Sunesis Waits Out Suspenseful Final Year of Pivotal Leukemia Trial 07/02/13 San Francisco
FDA Declines To Approve Aveo’s Drug For Kidney Cancer 06/10/13 Boston
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
Can (Should?) A Young Biotech Company Still Go Long? 12/20/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Reinventing Biotech’s Business Model: The Photos 10/18/12 San Francisco
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Roche Deal With Tiny Sunnyvale Biotech Revives Old Family Ties 09/25/12 San Francisco
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Join Us Oct. 16 for ‘Reinventing Biotech’s Business Model’ in SF 09/11/12 San Francisco
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
Page 1 of 4 next page »